Scientific Advisors
Scientific Advisors

Arbele's Global Scientific and Advisory Networks

Expertise Areas

  • Cancer Immunity
  • Cell biology and adhesion molecules
  • Clinical Oncology and Clinical Trials
  • Clinical Pathology and liver disease
  • General Surgery & HCC
  • Hematology, Oncology & Immunology
  • Healthy Ageing
  • Hepatitis B and liver cancer
  • Hepatitis infection and immunity
  • Infectious diseases & vaccine
  • Pediatrics cancers and stem cell therapy
  • T-cell immunology

Click the map locations to discover

Our Science

Arbele is positioned to be a leader in cancer immunotherapies for solid tumors. A central player in cancer immunotherapy is a type of white blood cell known as the T cell. In healthy individuals, T cells identify and kill infected or abnormal cells like tumors. However, cancer cells carrying the ability (especially in solid tumors) to evade immune surveillance is a key factor in their growth, spread, and persistence. We leverage two technologies - Chimeric Antigen Receptor (CAR) and Bi-specific Monoclonal Antibodies (BiMAbs) - to activate the patient's T cells so that they attack cancer cells.